Dossenheim, Germany

Söhnke Voss

This inventor holds 4 USPTO granted patents and 8 published patent applications and 6 EPO patents. Top assignees: Curevac Ag, Curevac Gmbh, Curevac Se. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Söhnke Voss. Retrieved from https://idiyas.com/inventor/söhnke-voss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 184(Granted Patents)


Location History:

  • Tübingen, DE (2016)
  • Dossenheim, DE (2015 - 2017)
  • Neckargemund, DE (2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Söhnke Voss: Innovator in Pharmaceutical Compositions

Introduction

Söhnke Voss is a notable inventor based in Dossenheim, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative immunostimulatory responses. With a total of 4 patents to his name, Voss continues to push the boundaries of medical science.

Latest Patents

One of Voss's latest patents is a pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen. This invention is directed towards creating a pharmaceutical composition that includes a polymeric carrier formed by disulfide-crosslinked cationic components. The composition aims to efficiently induce an adaptive immune response against various antigens associated with infectious diseases, allergies, autoimmune diseases, and cancer.

Another significant patent involves a composition comprising a complexed (M)RNA and a naked mRNA for enhancing an immunostimulatory response in mammals. This immunostimulatory composition includes an adjuvant component with at least one (m)RNA complexed with a cationic compound, along with free mRNA encoding therapeutically active proteins. This invention is designed to elicit or enhance both innate and adaptive immune responses, making it a valuable asset in the treatment of various diseases.

Career Highlights

Throughout his career, Söhnke Voss has worked with prominent companies in the biotechnology sector, including CureVac AG and CureVac GmbH. His work has focused on developing cutting-edge solutions in immunology and vaccine technology.

Collaborations

Voss has collaborated with notable professionals in his field, including Thomas Kramps and Mariola Fotin-Mleczek. These collaborations have further enriched his research and development efforts.

Conclusion

Söhnke Voss is a distinguished inventor whose work in pharmaceutical compositions has the potential to revolutionize treatments for various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…